# Investigating the Effects of Gardenia Polysaccharides on LPS-Induced Immune Injury in Mice and Exploring the Molecular Mechanisms Underlying Its Regulatory Effect on the Immune Function of Macrophages

**Authors:** Pingdong Lin, Wen Yue, Han Xiang, Jing Liu, Xinzhu Chen

PMC · DOI: 10.3390/foods14203455 · 2025-10-10

## TL;DR

This study shows that Gardenia polysaccharides protect mice from immune damage caused by LPS and boost macrophage function through a key immune signaling pathway.

## Contribution

The novel contribution is identifying the TLR4/NF-κB pathway as the mechanism through which Gardenia polysaccharides modulate macrophage immunity.

## Key findings

- Gardenia polysaccharides reversed LPS-induced immunosuppression and oxidative stress in mice.
- GP enhanced macrophage phagocytic activity and pro-inflammatory cytokine secretion via TLR4/NF-κB signaling.
- Fluorescence imaging confirmed NF-κB p65 nuclear translocation, supporting pathway activation.

## Abstract

This study investigated the protective effects of Gardenia jasminoides Ellis polysaccharides (GP) on lipopolysaccharide (LPS)-induced immunosuppression and oxidative stress in mice and explored how GP modulates macrophage polarization through the TLR4/NF-κB signaling axis. The results showed that GP notably restored thymus and spleen indices in LPS-treated mice, markedly decreased the serum concentrations of malondialdehyde, and enhanced superoxide dismutase activity and total antioxidant capacity. In RAW 264.7 macrophage cultures, GP displayed immunostimulatory effects by improving phagocytic activity, promoting NO synthesis, and enhancing the secretion of pro-inflammatory cytokines, including IL-1β, IL-6, and TNF-α. These effects were observed in cells not pretreated with TAK-242 or PDTC; however, they were not observed in cells pretreated with these inhibitors. At 300 µg/mL concentration, GP markedly enhanced the transcriptional levels of iNOS and cytokine genes. Protein analysis revealed significant upregulation of TLR4, MyD88, TRAF6, NF-κB RelA/p65, and phosphorylated p65. Fluorescence imaging confirmed the nuclear translocation of p65. Collectively, these findings indicated that GP reversed systemic immunosuppression and oxidative stress, offering foundational insights for developing natural immune regulators. The observed immunomodulatory properties of GP are likely mediated through the TLR4/NF-κB signaling pathway.

## Linked entities

- **Genes:** TLR4 (toll like receptor 4) [NCBI Gene 7099], MYD88 (MYD88 innate immune signal transduction adaptor) [NCBI Gene 4615], TRAF6 (TNF receptor associated factor 6) [NCBI Gene 7189], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790], NOS2 (nitric oxide synthase 2) [NCBI Gene 4843], IL1B (interleukin 1 beta) [NCBI Gene 3553], IL6 (interleukin 6) [NCBI Gene 3569], TNF (tumor necrosis factor) [NCBI Gene 7124]
- **Chemicals:** TAK-242 (PubChem CID 11703255), PDTC (PubChem CID 10176668), NO (PubChem CID 24822), malondialdehyde (PubChem CID 10964)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Nos2 (nitric oxide synthase 2, inducible) [NCBI Gene 18126] {aka MAC-NOS, NOS-II, Nos-2, Nos2a, i-NOS, iNOS}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Traf6 (TNF receptor-associated factor 6) [NCBI Gene 22034] {aka 2310003F17Rik, C630032O20Rik}, Myd88 (myeloid differentiation primary response gene 88) [NCBI Gene 17874], Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Rela (Rela proto-oncogene, NFKB subunit) [NCBI Gene 19697] {aka p65, p65 NF-kappa B, p65 NFkB}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}
- **Diseases:** inflammatory (MESH:D007249)
- **Chemicals:** malondialdehyde (MESH:D008315), Gardenia Polysaccharides (-), TAK-242 (MESH:C507035), NO (MESH:D009614), LPS (MESH:D008070), PDTC (MESH:C066229)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** RAW 264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12563339/full.md

---
Source: https://tomesphere.com/paper/PMC12563339